---
schema_version: "secwatch.filing_event.v1"
accession: "0001739614-24-000031"
form_type: "8-K"
ticker: null
cik: "0001739614"
company_name: "Inhibrx, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:33:16.978833+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Inhibrx reports Q1 results; Sanofi merger with $30/shr cash, CVR, and spin-off set for May 30

## Summary
- Sanofi to acquire INBRX-101 assets; shareholders receive $30/shr cash + $5 CVR + 1/4 share of New Inhibrx.
- Merger closing and spin-off expected May 30; special meeting May 24; when-issued trading of New Inhibrx (INXB) starts May 16.
- Q1 net loss $78.7M ($1.44/shr) vs $48.9M ($1.12/shr) YoY; R&D expense up 71% to $63.9M.
- Cash $252.5M at Mar 31, down from $277.9M at Dec 31; $38.7M in stock option proceeds.

## SEC filing metadata
- accession: 0001739614-24-000031
- form_type: 8-K
- cik: 0001739614
- company_name: Inhibrx, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000031/0001739614-24-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000031/inhibrx-20240509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001739614-24-000031
- JSON: https://secwatch.observer/filing/0001739614-24-000031.json
- Plain text: https://secwatch.observer/filing/0001739614-24-000031.txt

## Key facts
- Earnings Releases
  Inhibrx, Inc. reported the first quarter of 2024 results: net income $78.7 million, EPS $1.44 per share.
  - Period: the first quarter of 2024
  - Net income: $78.7 million
  - EPS: $1.44 per share
  - Result: reported results
  source text: Net loss was $78.7 million during the first quarter of 2024, or $1.44 per share, compared to $48.9 million during the first quarter of 2023, or $1.12 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739614/000173961424000031/0001739614-24-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.